37
Views
10
CrossRef citations to date
0
Altmetric
Article

PEA15 Regulates the DNA Damage-Induced Cell Cycle Checkpoint and Oncogene-Directed Transformation

, , , &
Pages 2264-2282 | Received 21 Nov 2013, Accepted 31 Mar 2014, Published online: 20 Mar 2023
 

Abstract

Regulation of the DNA damage response and cell cycle progression is critical for maintaining genome integrity. Here, we report that in response to DNA damage, COPS5 deubiquitinates and stabilizes PEA15 in an ATM kinase-dependent manner. PEA15 expression oscillates throughout the cell cycle, and the loss of PEA15 accelerates cell cycle progression by activating CDK6 expression via the c-JUN transcription factor. Cells lacking PEA15 exhibit a DNA damage-induced G2/M checkpoint defect due to increased CDC25C activity and, consequentially, higher cyclin-dependent kinase 1 (CDK1)/cyclin B activity, and accordingly they have an increased rate of spontaneous mutagenesis. We find that oncogenic RAS inhibits PEA15 expression and that ectopic PEA15 expression blocks RAS-mediated transformation, which can be partially rescued by ectopic expression of CDK6. Finally, we show that PEA15 expression is downregulated in colon, breast, and lung cancer samples. Collectively, our results demonstrate that tumor suppressor PEA15 is a regulator of genome integrity and is an integral component of the DNA damage response pathway that regulates cell cycle progression, the DNA-damage-induced G2/M checkpoint, and cellular transformation.

ACKNOWLEDGMENTS

We thank Angelika Amon and Mark Hochstrasser for helpful discussions and David Stern for his useful comments on the manuscript. We thank Darryl Conte for editorial assistance.

N.W. is a translational scholar of the Sidney Kimmel Foundation for Cancer Research and is supported by a Young Investigator Award from the National Lung Cancer Partnership, Uniting against Lung Cancer, and the International Association for the Study of Lung Cancer, Melanoma Research Alliance and Melanoma Research Foundation. M.R.G. is an investigator of the Howard Hughes Medical Institute. This work was supported in part by a grant from the NIH (R01GM033977) to M.R.G.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.